Edition:
United Kingdom

People: Idorsia Ltd (IDIA.S)

IDIA.S on Swiss Exchange

24.62CHF
23 Aug 2019
Change (% chg)

CHF0.20 (+0.82%)
Prev Close
CHF24.42
Open
CHF24.50
Day's High
CHF24.92
Day's Low
CHF24.30
Volume
417,732
Avg. Vol
327,770
52-wk High
CHF25.02
52-wk Low
CHF15.20

Braunstein, Guy 

Dr. Guy Braunstein serves as Executive Vice President, Head of Global Clinical Development, Member of the Executive Board at Idorsia Ltd. He joined Idorsia from Actelion, where he has worked since 2009. Prior to his position at Actelion, Dr. Braunstein was chief medical officer at Merck Serono, having served for four years before that as chief medical officer (international) at Serono. Previously, Dr. Braunstein held various executive positions at Astra, Glaxo-Wellcome, GSK, Fisons, Rhone-Poulenc Rorer and Chiron. Dr. Braunstein is an MD, pulmonologist and holds a Ph.D. in life science from Paris University, France.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --